Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Pancreatic Cancer × nimotuzumab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 18 Esophageal Squamous Cell Carcinoma 11 Esophageal Neoplasms 11 Uterine Cervical Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Pancreatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Head and Neck Neoplasms 6 Stomach Neoplasms 3 Neoplasms 3 Recurrence 2 Pancreatic cancer, adult 2 Neoplasm Metastasis 2 Nasopharyngeal Neoplasms 2 Lung Neoplasms 2 Diffuse Intrinsic Pontine Glioma 2 Colorectal Neoplasms 2 Carcinoma 2 Adenocarcinoma 2 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Anal Canal 1 Solid Tumors 1 Solid Tumor 1 Resectable Pancreatic Cancer 1 Penile Neoplasms 1 Pancreatic Cancer Resectable 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Diseases 1 NSCLC 1

Interventions

Gemcitabine 7 S 1 (combination) 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 toripalimab 3 Taxes 3 Nivolumab 2 Injections 2 Drug Therapy 2 penpulimab 1 pegylated granulocyte colony-stimulating factor 1 nimotuzumab 1 irinotecan sucrosofate 1 gimeracil 1 fluzoparib 1 envafolimab 1 endostar protein 1 conteltinib 1 cabiralizumab 1 apatinib 1 Tegafur 1 Simvastatin 1 Radiosurgery 1 Paclitaxel 1 Oxaliplatin 1 Metformin 1 Leucovorin 1 Irinotecan 1 Immunotherapy 1 IMM-101 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06422156 2024-05-20

Nim-PC-28

Peking University Third Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡